Covington Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Covington Capital Management's BIIB Position: Q2 2022 in Review
Covington Capital Management sold out of Biogen (BIIB) in Q2 2022, closing a stake of 3 shares — an estimated $1K sold.
Covington Capital Management first reported a position in BIIB in Q3 2017 and held it in 19 quarters. The position peaked at $75K in Q3 2017. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.
- Covington Capital Management reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
- Covington Capital Management sold 3 Biogen shares in Q2 2022, an estimated $1K.
- Covington Capital Management first reported a position in Biogen in Q3 2017 and held it in 19 quarters.
- Covington Capital Management's Biogen position peaked at $75K in Q3 2017.
- 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.
Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.